Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

2848results about How to "Minimize damage" patented technology

Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent

According to an aspect of the present invention, a medical device is provided, which comprises the following: (a) a hollow elongate body (e.g., a elongate cylinder, such as a needle) having distal and proximal ends; and (b) a rotatable member comprising a tissue morselizer and an elongate shaft (e.g., an auger-like tissue-drilling bit). In the devices of the present invention, the elongate shaft is disposed within the hollow elongate body and cooperates with the hollow elongate body to (i) advance material (e.g., morselated tissue) toward the proximal end of the hollow elongate body when the shaft is rotated in a first direction, and (ii) advance material (e.g., a therapeutic agent and/or a bulking agent) toward the distal end of the hollow elongate body when the shaft is rotated in a second direction that is opposite the first direction. According to another aspect of the invention a method of treatment is provided that comprises: (a) inserting the a medical device like that above into the tissue of a patient; (b) morselizing and removing tissue from within the patient while rotating the shaft in a first direction, thereby creating a void within the patient; and (c) introducing a therapeutic agent and/or a bulking agent into the void.
Owner:BOSTON SCI SCIMED INC

Deployment device, system and method for medical implantation

A deployment device for deploying a self-expansible medical implant at a target location in a body cavity, is provided. While generally, the expansion of self-expansible structures tends to be abrupt, and the impact of expansion may cause injury, a two-stage expansion process of the present invention minimizes the impact of exapnsion. Additionally, an ability to manuever the medical imlant into position, after the first stage of expansion, provides for accurate positioning. Thus the present invention is of a deployment device for precise and well-controlled manner of deployment, so as to minimize damage to the cavity wall and to position the implant accurately at the target location. The deployment device includes: an inner tube; an outer tube; and an implant received on the inner tube and enclosed by the outer tube. The implant has a self-expansible anchoring element which is in a contracted condition when enclosed by the outer tube, expands to a partially-expanded condition when the outer tube is retracted, and expands to a fully-expanded condition when the inner tube is removed.. The implant is deployed by introducing the deployment device to the target location in the body cavity; retracting the outer tube with respect to the implant such that the anchoring element self-expands from its contracted condition to its partially-expanded condition; and withdrawing the inner tube from the implant such that the anchoring element self-expands from its partially-expanded condition to its fully-expanded condition to firmly fix the implant at the target location within the body cavity.
Owner:REMON MEDICAL TECH

Electrosurgical apparatus having digestion electrode and methods related thereto

InactiveUS6896674B1High trafficAvoid and minimize current shortingHeart valvesEndoscopesHigh frequency powerDigestion
Methods and apparatus for resecting and ablating tissue at a target site of a patient, the apparatus including a probe having an elongate shaft. The shaft includes a shaft distal end portion and a shaft proximal end portion, and a resection unit located at the shaft distal end portion. The resection unit includes a resection electrode support and at least one resection electrode arranged on the resection electrode support. The at least one resection electrode includes a resection electrode head. The probe and resection electrode head are adapted for concurrent electrical ablation and mechanical resection of target tissue. The shaft may include at least one digestion electrode capable of aggressively ablating resected tissue fragments. At least one fluid delivery port on the shaft distal end portion may provide an electrically conductive fluid to the resection unit or to the target site. The shaft may include at least one aspiration port, located proximal to the resection unit, for aspirating excess or unwanted fluids and resected tissue fragments from the target site. The at least one aspiration port is coupled to an aspiration lumen. The at least one digestion electrode may be arranged within the aspiration lumen for ablation of tissue fragments therein. In use, the digestion and resection electrodes of the probe are coupled to a high frequency power supply. A surgical kit comprising the probe is also disclosed, together with a method of making the probe.
Owner:ARTHROCARE

Dual mode electrosurgical clamping probe and related methods

The present invention provides systems, apparatus and methods for selectively applying electrical energy to body tissue in order to ablate, contract, coagulate, or otherwise modify a target tissue or organ of a patients. An electrosurgical apparatus of the invention includes a shaft having a shaft distal end bearing an active electrode and a return electrode. At least one of the active electrode and the return electrode is moveable such that the shaft distal end can adopt a closed configuration or an open configuration. The apparatus can operate in an ablation mode or a sub-ablation mode. The closed configuration is adapted for clamping and coagulating a target tissue while the apparatus is operating in the sub-ablation mode, while the open configuration is adapted for ablating the target tissue via molecular dissociation of tissue components. A method of the present invention comprises clamping a target tissue or organ with an electrosurgical probe. A first high frequency voltage is applied between the active electrode and the return electrode to effect coagulation of the clamped tissue. Thereafter, a second high frequency voltage is applied to effect localized molecular dissociation of the coagulated tissue. The present invention allows the ablation or modification of the target tissue with minimal or no damage to surrounding, non-target tissue.
Owner:ARTHROCARE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products